Overexpression of DJ-1 has been reported in lung, prostate and breast cancers [3, 4], and DJ-1 appearing in serum can serve as a biomarker for indicating malignancy of breast cancer [5] and melanoma [6]. The gene discussed is PARK7; the disease is breast carcinoma.